Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives
Open accessThe DOI matches its Crossref record; 187 of the 189 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Stroke is the second leading cause of death and a major contributor to disability worldwide. The prevalence of stroke is highest in developing countries, with ischemic stroke being the most common type. Considerable progress has been made in our understanding of the pathophysiology of stroke and the underlying mechanisms leading to ischemic insult. Stroke therapy primarily focuses on restoring blood flow to the brain and treating stroke-induced neurological damage. Lack of success in recent clinical trials has led to significant refinement of animal models, focus-driven study design and use of new technologies in stroke research. Simultaneously, despite progress in stroke management, post-stroke care exerts a substantial impact on families, the healthcare system and the economy. Improvements in pre-clinical and clinical care are likely to underpin successful stroke treatment, recovery, rehabilitation and prevention. In this review, we focus on the pathophysiology of stroke, major advances in the identification of therapeutic targets and recent trends in stroke research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“UMNDs may occur because of a traumatic event, nontraumatic event, or inherited or sporadic neurodegenerative disease.1,3–8”
From Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review (2022) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedTissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundHeart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388 · cited 1×
“Atrial fibrillation (AF): AF is an important risk factor for stroke, increasing risk two- to five-fold depending upon the age of the individual concerned [50].”
BackgroundIntravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149 · cited 1×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundBlood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491 · cited 1×
“A study reported that a 5–6 mm Hg reduction in BP lowered the relative risk of stroke by 42% [44].”
BackgroundO'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundJohnson, C. O., Nguyen, M., Roth, G. A., Nichols, E., Alam, T., Abate, D., Abd-Allah, F., Abdelalim, A., Abraha, H. N., Abu-Rmeileh, N. M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30034-1 · Cited by 3,264 · cited 3×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundMethod
Research works printed but not linked: 2
- Rollin B.E. The Experimental Animal in Biomedical Research: Care, Husbandry and Well-Being: An Overview by Species Kesel M.L. CRC Press Boston, MA, USA 1995
- VE O.C. GA D. MR M. DW H. Animal models of stroke versus clinical stroke: Comparison of infarct size, cause, location, study design, and efficacy of experimental therapies Animal Models for the Study of Human Disease Michael Conn P. Academic Press Waltham, MA, USA 2013 531 568
Cited by
Items 101–200 of 1,001
Quest for Quality in Translational Stroke Research—A New Dawn for Neuroprotection?
Haupt, M., Gerner, S. T., Bähr, M., & Doeppner, T. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105381 · Cited by 33
“In ischemic stroke, impaired perfusion results in an acute glucose and oxygen deficiency, which leads to insufficient anerobic adenosine triphosphate (ATP) production, followed by lactate acidosis and disturbed cellular homeostasis [6].”
BackgroundInfluentialNeuroinflammation: A Critical Factor in Neurodegenerative Disorders
Khoury, Z. S., Sohail, F., Wang, J., Mendoza, M., Raake, M., Silat, M. T., Bathinapattla, M. R., Sadeghzadegan, A., Meghana, P., & Paul, J. (2024) · Cureus · doi:10.7759/cureus.62310 · Cited by 44
The Value of Optical Coherence Tomography Angiography (OCT-A) in Neurological Diseases
Augustin, A. J., & Atorf, J. (2022) · Diagnostics · doi:10.3390/diagnostics12020468 · Cited by 31
“Modifiable risk factors are hypertension, smoking, alcohol and drug abuse, diet, physical inactivity, hyperlipidemia, and diabetes mellitus [51].”
BackgroundChen, F., Liu, J., Liu, J., Wang, S.-S., Zhang, Y.-Y., Lu, Y.-Y., Lu, Y.-Y., & Yao, R. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.350204 · Cited by 30
“For example, excitotoxicity, inflammation, glial activation, oxidative stress, and free radical or pro-inflammatory cytokinemediated cytotoxicity have been reported to be involved in stroke pathology (Kuriakose and Xiao, 2020).”
BackgroundSocial Support and Depression among Stroke Patients: A Topical Review
Zhou, H., & Kulick, E. R. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20247157 · Cited by 41
“Based on the mechanisms, stroke typically consists of three types—ischemic stroke, hemorrhagic stroke, and transient ischemic attack (TIA) [1].”
BackgroundInfluentialKvistad, C. E., Kråkenes, T., Gavasso, S., & Bø, L. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1398089 · Cited by 42
“The following ATP depletion leads to an unbalanced intracellular influx of ions and water, culminating in the breakdown of neural cell membranes (17).”
BackgroundThe link between Alzheimer’s disease and stroke: A detrimental synergism
Behl, T., Kaur, I., Sehgal, A., Khandige, P. S., Imran, M., Gulati, M., Anwer, M. K., Elossaily, G. M., Ali, N., Wal, P., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102388 · Cited by 38
Rohden, F., Teixeira, L. V., Bernardi, L. P., Ferreira, P. C. L., Colombo, M., Teixeira, G. R., de Oliveira, F. D. S., Lima, E. O. C., Guma, F. T. C. R., & Souza, D. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312860 · Cited by 33
“Ischemic stroke represents ~85% of total strokes [2], frequently causing neurological and neuropsychiatric sequelae [3–6].”
BackgroundSun, P., Zhang, S., Jiang, L., Ma, Z., Yao, C., Zhu, Q., & Fang, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.956316 · Cited by 29
“Quantitative electroencephalography (EEG) may also be a reliable instrument for detecting alterations of interhemispheric interaction poststroke that provide the functional electrical activity of neuronal assembles in the brain, including the integrity of the afferent sensory tract and the corticospinal tract as well…”
BackgroundHoseinzadeh, A., Johari, H. G., Anbardar, M. H., Tayebi, L., Vafa, E., Abbasi, M., Vaez, A., Golchin, A., Amani, A. M., & Jangjou, A. (2022) · European journal of medical research · doi:10.1186/s40001-022-00833-6 · Cited by 32
“In the medical community, stroke is described as a neurological deficiency caused by an acute focused central nervous system lesion caused by an artery [135].”
BackgroundTang, J. Y., Chen, Y., Li, J., Yan, S., Wang, Z., Deng, X., Feng, K., Zhang, Y., Chen, C., Geng, H., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14198 · Cited by 29
Luo, M., Liu, Y., Xu, X., Liu, K., Shen, C., Hu, H., He, Z., & Wu, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1158274 · Cited by 33
“30 mmol/L) were associated with a two-fold increased risk of death in stroke (Kuriakose and Xiao, 2020).”
BackgroundJiang, H., Zhang, C., Lin, M., Yin, Y., Deng, S., Liu, W., Zhuo, B., Tian, G., Du, Y., & Meng, Z. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102536 · Cited by 37
A Hybrid Deep Learning Approach for Improved Detection and Prediction of Brain Stroke
Thakre, G., Raut, R., Puri, C., & Verma, P. (2025) · Applied Sciences · doi:10.3390/app15094639 · Cited by 28
Jia, Y., Yi, L., Li, Q., Liu, T., & Yang, S. (2021) · Biological Research · doi:10.1186/s40659-021-00331-9 · Cited by 28
“Ischemic stroke is by far the most common type of stroke, accounting for about 87 % of all strokes [2].”
BackgroundMolecular mechanisms underlying some major common risk factors of stroke
Alkahtani, R. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10218 · Cited by 36
“However, reducing blood pressure in young and aged individuals by 5–6 mmHg decreased the risk of stroke by 42% [56, 57, 58].”
BackgroundAIM2 inflammasome: A potential therapeutic target in ischemic stroke
Fu, R., Zhao, L., Guo, Y., Qin, X., Xu, W., Cheng, X., Zhang, Y., & Xu, S. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109881 · Cited by 30
Estimating the economic burden of stroke in China: a cost-of-illness study
Ma, J., Tian, Z., Chai, P., Wan, Q., Zhai, T., Guo, F., & Li, Y. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080634 · Cited by 29
Mechanisms of Postischemic Stroke Angiogenesis: A Multifaceted Approach
Hu, B., Pei, J., Wan, C., Liu, S., Xu, Z., Zou, Y., Li, Z., & Tang, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s461427 · Cited by 34
Salivary Xanthine Oxidase as a Potential Biomarker in Stroke Diagnostics
Maciejczyk, M., Nesterowicz, M., Zalewska, A., Biedrzycki, G., Gerreth, P., Hojan, K., & Gerreth, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897413 · Cited by 30
“Ischemic stroke is caused by closure/constriction of intracerebral vessels and hemodynamic abnormalities resulting in slowed cerebral flow, whereas hemorrhagic stroke occurs due to blood extravasation within the brain tissue (2).”
BackgroundFatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets
Guo, Q., Kawahata, K., Cheng, A., Jia, W., Wang, H., & Fukunaga, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179648 · Cited by 31
“CI/RI is a multi-faceted and complex pathophysiological process involving multiple interrelated events, including energy exhaustion, intracellular calcium overload, excitotoxicity, mitochondrial dysfunction, oxidative stress, inflammation, microglial activation, blood–brain barrier (BBB) disruption, and leukocyte infi…”
BackgroundYang, S.-E., Lien, J., Tsai, C.-W., & Wu, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810394 · Cited by 32
“In addition, daidzein produced the vascular relaxation response in a rabbit basilar artery and this effect was not blocked by L-NAME, 1H- [1,2,4] oxadiazolo [4, 3-a] quinoxalin-1-one (selective inhibitor of NO-sensitive guanylyl cyclase), 4H-8-bromo-1,2,4oxadiazolo (3, 4-d) benz (b) (1,4) oxazin-1-one (specific solubl…”
BackgroundIschemic Stroke Impacts the Gut Microbiome, Ileal Epithelial and Immune Homeostasis
Ge, Y., Zadeh, M., Yang, C., Candelario‐Jalil, E., & Mohamadzadeh, M. (2022) · iScience · doi:10.1016/j.isci.2022.105437 · Cited by 33
“Thus, intensified efforts tomechanistically understand the pathophysiology of stroke and stem the tide of this disease are of the utmost importance.(14) Considering the ubiquity of this disease, identifying reversible risk factors or new therapeutic targets will have an outsized impact on the global disease burden.”
BackgroundGong, Z., Ding, Y., Chen, Y., & Cree, M. J. (2023) · IEEE Transactions on Antennas and Propagation · doi:10.1109/tap.2023.3283131 · Cited by 27
“While it is possible for a person to experience multiple strokes at different times, it is less common to have two stroke events simultaneously in two different subareas of the brain [3].”
BackgroundZhao, X., Wang, Z., Wang, J., Xu, F., Zhang, Y., Han, D., & Fang, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111396 · Cited by 29
Navigating the brain: the role of exosomal shuttles in precision therapeutics
Fatima, S., Qaiser, A., Andleeb, S., Hashmi, A. H., & Manzoor, S. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2023.1324216 · Cited by 30
“A stroke, often known as a brain attack, is caused by an abrupt rupture of a blood vessel in the brain or an obstruction of blood flow to the brain, and it can be either ischemic or hemorrhagic (102).”
BackgroundHaupt, M., Gerner, S. T., & Doeppner, T. R. (2024) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.39 · Cited by 36
Wang, S., Rao, B., Chen, L., Chen, Z., Fang, P., Miao, G., Xu, H., & Liao, W. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.724267 · Cited by 29
Thomas, S. D., Jha, N. K., Sadek, B. S., & Ojha, S. K. (2022) · Pharmaceuticals · doi:10.3390/ph15050497 · Cited by 28
“Stroke, also known as cerebral ischemia, is one of the leading causes of death globally, and on the basis of its developmental etiology is primarily derived from hemorrhagic complications or ischemia, with the latter being more common [41].”
BackgroundTherapeutic potential of puerarin against cerebral diseases: From bench to bedside
Liu, T., Su, K., Cai, W., Ao, H., & Li, M. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175695 · Cited by 26
The Role of ADAMTS-4 in Atherosclerosis and Vessel Wall Abnormalities
Novak, R., Hrkač, S., Salai, G., Bilandžić, J., Mitar, L., & Grgurević, L. (2022) · Journal of Vascular Research · doi:10.1159/000521498 · Cited by 25
Breedam, E. V., & Ponsaerts, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137140 · Cited by 28
“Moreover, mice are often used, since they are helpful in unravelling the function of certain genes in the pathophysiology of stroke by means of the creation of transgenic mice [3,7,11].”
BackgroundMethodInfluentialJin, L., Jin, W., Zeng, Q., Li, Y., Yang, J., Wan, H., & He, Y. T. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154814 · Cited by 26
Electrocardiogram Features in Non-Cardiac Diseases: From Mechanisms to Practical Aspects
Ceasovschih, A., Șorodoc, V., Covanţev, S., Balta, A., Uzokov, J., Kaiser, S., Almaghraby, A. M., Lionte, C., Stătescu, C., Sascău, R. A., et al. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s445549 · Cited by 29
The role of ACSL4 in stroke: mechanisms and potential therapeutic target
Zhuo, B., Qin, C., Deng, S., Jiang, H., Si, S., Tao, F., Cai, F., & Meng, Z. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05150-6 · Cited by 29
“Ischemic stroke, which is caused by local blood supply disorders in brain tissue for various reasons, leads to the necrosis of hypoxic lesions in brain tissue and then induces the clinical corresponding manifestation of neurological function [132, 133].”
Yadava, S., Dontiboina, H. R., Nakka, V. P., Anusha, V. L., Dumala, N., Viswanadh, M. K., Chakravarthi, G., Nalluri, B. N., & Ramakrishna, K. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.024 · Cited by 29
Yadav, V. K., Gupta, R., Assiri, A. A., Uddin, J., Ishaqui, A. A., Kumar, P., Orayj, K. M., Tahira, S., Patel, A., & Choudhary, N. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16010008 · Cited by 28
“One of the major hurdles in stroke is the restricted regenerative capacity of neurons in the affected brain region [38,39].”
Chen, Z., Wu, H., & Zhang, M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105101 · Cited by 26
Role of oncostatin-M in ECM remodeling and plaque vulnerability
Patel, P. R., Rai, V., & Agrawal, D. K. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04673-8 · Cited by 28
“This vascular inflammatory disease is caused by the buildup of plaque in vasculature throughout the body which, upon rupture can cause acute outcomes like stroke and myocardial infarction (MI) [2].”
BackgroundHerath, H. M. D. P. M., Weraniyagoda, W. A. S. A., Rajapaksha, R. T. M., Wijesekara, P. A. D. S. N., Sudheera, K. L. K., & Chong, P. H. J. (2022) · Sensors · doi:10.3390/s22186966 · Cited by 23
“Stroke is a condition that occurs with the death of brain cells due to poor blood flow toward certain parts of the brain [1].”
BackgroundMechanistic insights of neuronal death and neuroprotective therapeutic approaches in stroke
Li, C., Luo, Y., & Li, S. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01324 · Cited by 36
“The penumbra contains neurons that are at high risk of imminent infarction due to the ischemic insult but still retain the potential for salvage through timely intervention (Moskowitz et al., 2010; Kuriakose and Xiao, 2020; Figure 3 ).”
Diaconescu, B. I., Dumitru, A. V., Tătaru, C. P., Toader, C., Șerban, M., Covache-Busuioc, R.-A., & Eva, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210835 · Cited by 27
“Despite advances in the acute management and vascular recanalization of strokes, the heterogeneity in stroke outcomes underscores that the ultimate neurological deficit experienced by individuals who have had a stroke cannot be solely attributed to macrovascular events [4].”
Zhang, S., Zhu, T., Li, Q., Sun, G., & Sun, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.765075 · Cited by 24
Acute glycemic variability and mortality of patients with acute stroke: a meta-analysis
Lin, J., Cai, C., Xie, Y., & Li, Y. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00826-9 · Cited by 23
“Pathophysiologically, stroke is defined as an abrupt neurological outburst caused by impaired perfusion through the blood vessels to the brain [5].”
BackgroundGuo, Y., Yang, Y., Cao, F., Wang, M., Luo, Y., Guo, J., Liu, Y., Zeng, X., Miu, X., Zaman, A., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185364 · Cited by 25
de Azevedo, J. A., Barbosa, F. D. S., Seixas, V. M., Scipioni, K. R. D. D. S., Sampaio, P. Y. S., da Cruz, D. M. C., Piscitelli, D., Chui, K. K., & Zanona, A. D. F. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.987061 · Cited by 23
López-Pedrera, C., Oteros, R., Ibáñez‐Costa, A., Luque-Tévar, M., Muñoz-Barrera, L., Barbarroja, N., Chicano‐Gálvez, E., Marta-Enguita, J., Orbe, J., Velasco, F., et al. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.04.015 · Cited by 23
Varlamova, E. G., Uspalenko, N. I., Khmil, N. V., Shigaeva, M. I., Stepanov, M. R., Ananyan, M. A., Timchenko, M., Molchanov, M. V., Mironova, G. D., & Turovsky, E. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411436 · Cited by 24
“Nevertheless, two thirds of stroke survivors remain essentially disabled with a low quality of life [1].”
BackgroundOcagli, H., Berti, G., Rango, D., Norbiato, F., Chiaruttini, M. V., Lorenzoni, G., & Gregori, D. (2023) · Nutrients · doi:10.3390/nu15194103 · Cited by 30
“Strokes are a leading cause of adult disability and the second leading cause of death worldwide, accounting for approximately 6.2 million deaths yearly [6].”
BackgroundMethodInfluentialPayne, C. T., Tabassum, S., Wu, S., Hu, H., Gusdon, A. M., Choi, H. A., & Ren, X. S. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1278334 · Cited by 25
“…inflammation, cytokine-mediated toxicity, complement activation, tissue Payne et al. 10.3389/fncel.2023.1278334 Frontiers in Cellular Neuroscience 02 frontiersin.org swelling, impairment of the blood–brain barrier (BBB), and free radical toxicity (Petraglia et al., 1987; Kuriakose and Xiao, 2020).”
BackgroundInfluentialWu, H., Fan, Y., & Zhang, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112637 · Cited by 26
“Considering the global health burden imposed by stroke, especially in developing countries, the imperative for more effective treatments to enhance post-stroke management becomes increasingly urgent [38].”
BackgroundEmerging Roles of Exosomes in Stroke Therapy
Larson, A. S., Natera-Rodriguez, D. E., Crane, A. T., Larocca, D., Low, W. C., Grande, A. W., & Lee, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126507 · Cited by 22
“However, currently, no drugs are available on the market to promote neurological recovery and neurovascular remodeling [9].”
BackgroundLi, X., He, Y., Wang, D., & Momeni, M. R. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01514-w · Cited by 38
“…intracellular calcium levels, excitotoxicity, toxicity induced by free radicals, cytotoxicity mediated by cytokines, activation of the complement system, compromised integrity of the blood–brain barrier (BBB), stimulation of glial cells, oxidative stress, and infiltration of leukocytes [32].”
Kaempferol promotes angiogenesis through HIF-1α/VEGF-A/Notch1 pathway in ischemic stroke rats
Zhang, S., Liu, C., Wan, L., Zhang, Y., Yang, Y., Yang, H., Zhao, Z., Xu, F., Cao, W., Li, X., et al. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.105953 · Cited by 24
Role of Mitophagy in the Pathogenesis of Stroke: From Mechanism to Therapy
Zhong, W.-J., Yang, X., Zhou, H., Xie, B.-R., Liu, W., & Li, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6232902 · Cited by 26
“However, there are still limitations in the existing treatment [10].”
Jin, J., Zhu, C., Wang, J., Zhao, X., & Yang, R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.972566 · Cited by 24
“MI and ischemic stroke are characterized by the build–up of plaque which decreases blood flow and eventually blocks the blood vessels (49, 50).”
BackgroundResearch progress on astrocyte autophagy in ischemic stroke
Su, P., Zhai, Z., Wang, T., Zhang, Y., Wang, Y., Ma, K., Han, B.-B., Wu, Z.-C., Yu, H.-Y., Zhao, H., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.951536 · Cited by 25
Role of tRNA-Derived Fragments in Neurological Disorders: a Review
Mathew, B. A., Katta, M., Ludhiadch, A., Singh, P., & Munshi, A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03078-w · Cited by 28
Montiel, T., Gómora‐García, J. C., Gerónimo‐Olvera, C., Heras‐Romero, Y., Bernal‐Vicente, B. N., Pérez-Martínez, X., Tovar‐y‐Romo, L. B., & Massieu, L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15852 · Cited by 24
“However, prolonged UPR can also lead to apoptosis and contribute to acute brain injury (Han et al., 2021; Kurtishi et al., 2019; Wang et al., 2022).”
BackgroundMulti-Channel FES Gait Rehabilitation Assistance System Based on Adaptive sEMG Modulation
Lu, C., Ge, R., Tang, Z., Fu, X., Zhang, L., Yang, K., & Xu, X. H. (2023) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2023.3313617 · Cited by 22
Singh, A. A., Kharwar, A. K., & Dandekar, M. P. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210907092928 · Cited by 33
“Newer therapies targeting both the areas of interest and other peripheral mechanisms that are altered in ischemic attack can be of some clinical importance, such as neurotrophins and stem cell therapy [10].”
Genetic Regulatory Networks of Apolipoproteins and Associated Medical Risks
Basavaraju, P., Balasubramani, R., Kathiresan, D. S., Devaraj, I., Babu, K., Vasanthakumar, A., & Moorthi, P. V. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.788852 · Cited by 24
Liang, H., Chang, X., Xia, R., Wei, W., Guo, H., & Yang, M. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2131561 · Cited by 21
“It affects around 13.7 million people and kills roughly 5.5 million annually [1].”
InfluentialA Cohesive Shear-Thinning Biomaterial for Catheter-Based Minimally Invasive Therapeutics
Baidya, A., Haghniaz, R., Tom, G., Edalati, M., Kaneko, N., Alizadeh, P., Tavafoghi, M., Khademhosseini, A., & Sheikhi, A. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c08799 · Cited by 21
Predictors of Short-Term Mortality in Patients with Ischemic Stroke
Iluţ, S., Vesa, Ș. C., Văcăraș, V., & Mureșanu, D.-F. (2023) · Medicina · doi:10.3390/medicina59061142 · Cited by 27
“Despite advances in acute stroke management, including thrombolysis and endovascular therapy, the overall mortality rate of ischemic stroke remains high, particularly in patients with severe strokes [2].”
BackgroundTeng, C., Lv, W., Chen, Y., Liu, L., Yin, J., Li, S., Min, Z., Zhang, Q., He, W., Ma, K., et al. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123748 · Cited by 26
Cao, J., Zeng, Y., Zhou, Y., Yao, Z., Tan, Z., Huo, G., Zhang, L., & Zhou, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-90319-2 · Cited by 20
Astrocyte heterogeneity in ischemic stroke: Molecular mechanisms and therapeutic targets
Li, D., Huo, X., Shen, L., Qian, M., Wang, J., Mao, S., Chen, W., Li, R. Q., Zhu, T., Zhang, B., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106885 · Cited by 30
“After the occurrence of cerebral ischemia, brain tissue will be subjected to various detrimental effects including cellular necrosis, disruption of the BBB, neuroinflammation, oxidative stress, excitotoxicity etc (Kuriakose and Xiao, 2020).”
Jittiwat, J., Suksamrarn, A., Tocharus, C., & Tocharus, J. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119842 · Cited by 20
Ren, Z., Sun, W., Wang, S., Ying, J., Liu, W., Fan, L., Zhao, Y. W., Wu, C., & Song, P. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.07.023 · Cited by 22
Li, S., Guo, B., Yang, Q., Yin, J., Tian, L., Zhu, H., Ji, Y., Zhou, Z., & Jiang, Y. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103252 · Cited by 24
Immune regulation based on sex differences in ischemic stroke pathology
Niu, P., Li, L., Zhang, Y., Su, Z., Wang, B., Liu, H., Zhang, S., Qiu, S., & Li, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1087815 · Cited by 25
Astrocytes in ischemic stroke: Crosstalk in central nervous system and therapeutic potential
Liu, J., Guo, Y., Zhang, Y., Zhao, X., Fu, R., Hua, S., & Xu, S. (2023) · Neuropathology · doi:10.1111/neup.12928 · Cited by 21
Zhuang, F., Shi, X., Qiao, S., Liu, B., Wang, Z., Huo, H., Liang, F., Shen, L., Zhu, L., He, B., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01633-5 · Cited by 24
“Stroke is one of the most vital vascular events in the central nervous system and is the second leading cause of death and disability in modern society [1].”
BackgroundPanbhare, K., Pandey, R., Chauhan, C., Sinha, A., Shukla, R., & Kaundal, R. K. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00536 · Cited by 24
Mesenchymal stem cell therapy in ischemic stroke trials. A systematic review
Moñivas, E., & Mercedes, Z. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.03.026 · Cited by 23
“Improvement in animal models, adoption of new technologies, and the implementation of innovative treatments are imperative [7].”
BackgroundResearch progress of active compounds from traditional Chinese medicine in the treatment of stroke
Yin, X., Li, S., Wang, J., Wang, M., & Yang, J. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117599 · Cited by 21
Lisek, M., Bochenska, N., Tomczak, J., Duraj, J., & Boczek, T. (2025) · Antioxidants · doi:10.3390/antiox14081015 · Cited by 23
“Due to the high density of ionotropic glutamate receptors and overall high metabolic activity, hippocampal neurons and RGCs are especially vulnerable to excitotoxic damage [11,12].”
Maes, M. H. J., Nikiforov, N. G., Plaimas, K., Suratanee, A., Alfieri, D. F., & Reiche, E. M. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212108 · Cited by 19
“Acute ischemic stroke (IS) is one of the most prevalent major health problems worldwide, which frequently causes severe functional disabilities and mortality [1,2].”
BackgroundMethodHa, G., Kim, E. J., Park, J. S., Kim, J. E., Nam, H., Yeon, J. Y., Lee, S.-H., Lee, K.-H., Kim, C. K., & Joo, K. M. (2022) · Aging · doi:10.18632/aging.204410 · Cited by 21
Perspective insights into hydrogels and nanomaterials for ischemic stroke
Yu, Q., Zhang, J., Yang, D., & Zhu, T. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1058753 · Cited by 20
“When cerebral arteries are occluded by embolism and thrombi, the blood flow supply to the corresponding brain territory is significantly decreased or blocked, leading to the failed energy metabolites delivery and oxygen deprivation, and thus inducing the pathological processes of IS (Kuriakose and Xiao, 2020).”
BackgroundKim, H., Lee, E., Jung, J., & Lee, S. (2023) · Vision · doi:10.3390/vision7040075 · Cited by 19
“In the realm of stroke recovery, an integrated approach to rehabilitation is essential, melding physical, occupational, speech, and cognitive therapy to facilitate functional restoration [6].”
BackgroundThe Role of Biomarkers in Atherothrombotic Stroke—A Systematic Review
Andone, S. R., Bajkó, Z., Moțățăianu, A., Mosora, O., & Bălașa, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169032 · Cited by 24
Bhogale, D., Mazahir, F., & Yadav, A. K. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02882-8 · Cited by 20
“Both ischemic and hemorrhagic stroke ultimately cause neuronal cell death [6].”
BackgroundAnemia and cerebrovascular disease: pathophysiological insights and clinical implications
Obeagu, E. I., & Obeagu, G. U. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002907 · Cited by 21
“However, this initial screening test is not sufficient on its own to assess the severity of the disease or its underlying cause [ 27 ] .”
Wu, Z., Zhang, Y., Liu, Y., Chen, X., Huang, Z., Zhao, X., He, H., & Deng, Y. (2021) · Life · doi:10.3390/life11090948 · Cited by 18
“injury is the direct pathogenesis of brain damage after stroke [5].”
BackgroundAlharbi, A. R., Alali, A. S., Samman, Y. M., Alghamdi, N. A., Albaradie, O. A., Almaghrabi, M. T., Makkawi, S., Alghamdi, S., Alzahrani, M. S., Alsalmi, M., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.951283 · Cited by 19
“Several risk factors were found to be linked to stroke, including unmodifiable risk factors such as genetics, gender, and age, and modifiable risk factors such as hypertension, dyslipidemia, diabetes mellitus, atrial fibrillation, cigarette smoking, and sedentary lifestyle (Kuriakose and Xiao, 2020; Sayed et al., 2022…”
BackgroundGuo, S., Xing, N., Xiang, G., Zhang, Y., & Wang, S. (2023) · Food & Function · doi:10.1039/d2fo03417d · Cited by 19
Clinical experience: Outcomes of mesenchymal stem cell transplantation in five stroke patients
Erçelen, N., Karasu, N., Kahyaoglu, B., Çerezci, Ö., Akduman, R. C., Ercelen, D., Erturk, G., Gulay, G. R., Alpaydin, N., Boyraz, G., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1051831 · Cited by 21
Johansen, T. E. B., Sørensen, L., Kolskår, K. K., Strøm, V., & Wouda, M. F. (2023) · Journal of Rehabilitation and Assistive Technologies Engineering · doi:10.1177/20556683231183639 · Cited by 32
“neuronal dysfunction.(3) Most stroke patients survive the initial injury, however long-term disabilities affecting activities of daily living and participation are common.”
BackgroundSethiya, N. K., Ghiloria, N., Srivastav, A., Bisht, D., Chaudhary, S. K., Walia, V., & Alam, M. S. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230718105358 · Cited by 25
A review of concepts and methods for FTIR imaging of biomarker changes in the post-stroke brain
Boseley, R. E., Sylvain, N. J., Peeling, L. M., Kelly, M., & Pushie, M. J. (2024) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2024.184287 · Cited by 20
Chen, L., Xiong, Y., Chopp, M., & Zhang, Y. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1376601 · Cited by 21
“Traumatic brain injury (TBI) and stroke are prominent causes of global disability and mortality, and impose a significant social and economic burden (Hyder et al., 2007; Lackland et al., 2014; Johnson and Griswold, 2017; Kuriakose and Xiao, 2020; Hering and Shetty, 2023).”
BackgroundMeng, W., Zhu, C. J., Liu, H., Liu, Q., & Xie, S. Q. (2024) · IEEE Transactions on Medical Robotics and Bionics · doi:10.1109/tmrb.2024.3385798 · Cited by 22
“Passive mode tends to be adopted at this stage, and patients can follow robot to perform periodic reciprocating movement [117], [118].”
BackgroundtRNA Modifications and Dysregulation: Implications for Brain Diseases
Lv, X., Zhang, R., Li, S., & Jin, X. K. (2024) · Brain Sciences · doi:10.3390/brainsci14070633 · Cited by 18
Cost-Effectiveness of Upper Extremity Dry Needling in Chronic Stroke
Fernández, D., la Cruz, N. B., Jiménez‐Sánchez, C., Gil-Calvo, M., Herrero, P., & Calvo, S. (2022) · Healthcare · doi:10.3390/healthcare10010160 · Cited by 18
“Stroke is a major contributor to disability worldwide, and the second leading cause of death in Spain [1,2], generating a great impact on patients´ quality of life (QOL) due to the functional limitations that it entails [3].”
BackgroundMethodInfluentialLu, W., Hou, D., Chen, X., Zhong, P., Liu, X., & Wu, D. (2023) · BMC Neurology · doi:10.1186/s12883-023-03348-7 · Cited by 17
“Ischemia and reperfusion (IR), which occur in acute ischemic stroke (AIS), can result in various detrimental effects such as neuroinflammation, peroxidation, and increased permeability of the vessels, apoptosis, necrosis, and blood-brain barrier (BBB) injury [22–24].”
BackgroundNatural essential oils: A promising strategy for treating cardio-cerebrovascular diseases
Long, Y., Li, D. X., Yu, S., Zhang, Y., Liu, S., Wan, J., Shi, A., Deng, J., Wen, J., Li, X., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115421 · Cited by 19
Gong, P., Tian, Q., He, Y., He, P., Wang, J., Guo, Y., Ye, Q., & Li, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113234 · Cited by 19
Docosahexaenoic acid inhibits ischemic stroke to reduce vascular dementia and Alzheimer’s disease
Yamagata, K. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106733 · Cited by 18
Metadata
- Authors
- Kuriakose, D., & Xiao, Z.
- Affiliations
- Monash University (AU)
- Development and Stem Cells Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC 3800, Australia
- ORCID
- Kuriakose, Diji
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-15
- Volume
- 21
- Issue
- 20
- Pages
- 7609
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7589849
- OpenAlex
- W3093285665
- Semantic Scholar
- f44478fa13b48c2e68d010e69172d6d21ab09e66
- Cited by
- 1,350
- References
- 189
- Citations by year
- 2026: 154 · 2025: 291 · 2024: 346 · 2023: 300 · 2022: 196 · 2021: 63
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Apex Biotech Research (NA)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- stroke, ischemic stroke, stroke pathophysiology, stroke treatment, reperfusion therapy, neurological damage, animal models of stroke, stroke rehabilitation, stroke prevention, therapeutic target, post-stroke care
- MeSH terms
- Stroke Rehabilitation, Animals, Fibrinolytic Agents, Humans, Risk Factors, Neuroprotective Agents, Stroke, Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


